Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human fetal mesenchymal stem cells.

Keelin O'Donoghue1, Jerry Chan

  • 1Experimental Fetal Medicine Group, Institute of Reproductive and Developmental Biology, Imperial College London, and Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Hammersmith Hospital Campus, London, UK. k.odonoghue@imperial.ac.uk

Current Stem Cell Research & Therapy
|January 29, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How does maternal "belief in a dangerous world" affect maternal and child depressive symptoms during times of crisis?

Journal of affective disorders reports·2026
Same author

Understanding maternal sleep position behaviour in the third trimester of pregnancy: A national cross-sectional mixed-methods study.

Women and birth : journal of the Australian College of Midwives·2026
Same author

The role of Coroners in perinatal death investigation in high-income countries: a scoping review.

Journal of perinatal medicine·2026
Same author

Medicine and motherhood: a cross-sectional survey of the experiences of women doctors in the Republic of Ireland.

BMC women's health·2026
Same author

Associations of preconception retinal microvasculature with lipid profiles from mid-pregnancy to three months postpartum.

NPJ cardiovascular health·2026
Same author

Evaluating online information on reduced fetal movements: a mixed-methods study.

Irish journal of medical science·2026
Same journal

Transplanted Cerebrospinal Fluid-Contacting Neurons Alleviate Spasticity Following Spinal Cord Injury in Mice.

Current stem cell research & therapy·2026
Same journal

Ear Cartilage Reconstruction: From Regenerative Medicine to Reconstructive Surgery.

Current stem cell research & therapy·2026
Same journal

Application of Wharton's Jelly Derived from Human Umbilical Cord in Tissue Engineering.

Current stem cell research & therapy·2026
Same journal

Gestational Age, Maternal Age, and Culture Dynamics Shape the Pluripotency Marker Profile of Primary Amniocytes: Insights for Stem Cell Biology and Regenerative Applications.

Current stem cell research & therapy·2026
Same journal

Outcomes of Chimeric Antigen Receptor T-cell (CAR-T) Cell Therapy in Hematological Malignancies - A Systematic Review and Meta Analysis.

Current stem cell research & therapy·2026
Same journal

Preface.

Current stem cell research & therapy·2026
See all related articles

Human fetal mesenchymal stem cells (hfMSC) possess superior self-renewal and differentiation capabilities compared to adult counterparts. These multipotent stem cells offer promising applications in fetal therapy and prenatal diagnosis.

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Immunology

Background:

  • The fetal environment facilitates unique stem cell migration patterns.
  • While fetal neural and hematopoietic stem cells (HSC) are well-studied, fetal mesenchymal stem cells (hfMSC) are recently characterized.
  • hfMSC exhibit greater self-renewal and differentiation potential than adult mesenchymal stem cells (MSC).

Purpose of the Study:

  • To characterize human fetal mesenchymal stem cells (hfMSC) from fetal blood, liver, and bone marrow.
  • To investigate the biological role and clinical applications of hfMSC, including their trafficking during pregnancy.
  • To explore the potential of hfMSC in fetal cellular and gene therapy and prenatal diagnosis.

Main Methods:

  • Isolation and characterization of non-hematopoietic, non-endothelial cells from human fetal tissues.

Related Experiment Videos

  • Immunophenotypic analysis comparing hfMSC to adult bone marrow-derived MSC.
  • Investigation of hfMSC circulation in first-trimester fetal blood and maternal trafficking.

    • Main Results:

    • Identified a population of hfMSC with superior self-renewal and differentiation capacity compared to adult MSC.
    • Demonstrated hfMSC circulation in fetal blood and trafficking into maternal bone marrow, leading to microchimerism.
    • Observed that hfMSC microchimerism's role in autoimmune disease pathogenesis is currently unknown.

    Conclusions:

    • hfMSC represent a unique stem cell population with significant therapeutic potential.
    • hfMSC trafficking during pregnancy has implications for maternal-fetal health and autoimmune disease.
    • Clinical applications include non-invasive prenatal diagnosis and fetal cell/gene therapy, potentially avoiding immune rejection and improving engraftment.